FDA 483 - Emerge Diagnostics, Inc. - April 26, 2019

Emerge Diagnostics, Inc. in Carlsbad, CA, a Class II Medical Device Manufacturer, was cited for three observations during an FDA inspection. The firm failed to adequately establish design change procedures for software and firmware, lacked documentation for design outputs, and did not properly document corrective actions, specifically technician training, for complaint investigations.